NeuroMetrix Files 510(k) for SENSUS(TM) Pain Therapy Device WALTHAM, Mass., Apr 18, 2012 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes reported today that it has filed a premarket
NeuroMetrix, Inc. Announces Date for 2012 First Quarter Financial Results Conference Call WALTHAM, Mass., Apr 17, 2012 (BUSINESS WIRE) --NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2012 first quarter financial results before the opening of the market on April 24, 2012.
NeuroMetrix to Exhibit at the Midwest Podiatry Conference WALTHAM, Mass. --(BUSINESS WIRE)--Apr. 10, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes reported today that it will exhibit at the
NeuroMetrix Announces Warrant Redemption WALTHAM, Mass. --(BUSINESS WIRE)--Mar. 13, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of neurological complications of diabetes, today announced plans to redeem warrants to purchase an aggregate